Search Results - A. B. Prokofiev

APPLIED ASPECTS OF SLCO1B1 PHARMACOGENETIC TESTING FOR PREDICTING OF STATIN-INDUCED MYOPATHY AND PERSONALIZATION OF STATINS THERAPY by D. A. Sychev, G. N. Shuev, A. B. Prokofiev

Connect to this object online.

APPLIED ASPECTS OF SLCO1B1 PHARMACOGENETIC TESTING FOR PREDICTING OF STATIN-INDUCED MYOPATHY AND PERSONALIZATION OF STATINS THERAPY by D. A. Sychev, G. N. Shuev, A. B. Prokofiev

Connect to this object online.

Susceptibility of HEK293 and RPTEC Cell Lines to Nephrotoxic Effects of Cefuroxime and Cefepime: A Comparative Study by V. A. Evteev, I. S. Semenova, N. D. Bunyatyan, A. B. Prokofiev

Connect to this object online.

Evaluation of Nephrotoxic Properties of Favipiravir Using the RPTEC cell model by V. A. Evteev, I. S. Semenova, N. D. Bunyatyan, A. B. Prokofiev

Connect to this object online.

APPLICATIONS OF PHARMACOGENETIC TESTING FOR PERSONALIZATION OF THERAPY WITH ORAL ANTICOAGULANTS IN RUSSIA by D. A. Sychev, R. E. Kazakov, V. A. Otdelenov, A. B. Prokofiev

Connect to this object online.

APPLICATIONS OF PHARMACOGENETIC TESTING FOR PERSONALIZATION OF THERAPY WITH ORAL ANTICOAGULANTS IN RUSSIA by D. A. Sychev, R. E. Kazakov, V. A. Otdelenov, A. B. Prokofiev

Connect to this object online.

THE SIGNIFICANCE OF PHARMACOGENETIC CYP2C19 TESTING FOR PERSONALIZATION OF THE ANTIPLATELET THERAPY IN CARDIOLOGY PRACTICE by K. B. Mirzaev, D. A. Sychev, D. A. Andreev, A. B. Prokofiev

Connect to this object online.

THE SIGNIFICANCE OF PHARMACOGENETIC CYP2C19 TESTING FOR PERSONALIZATION OF THE ANTIPLATELET THERAPY IN CARDIOLOGY PRACTICE by K. B. Mirzaev, D. A. Sychev, D. A. Andreev, A. B. Prokofiev

Connect to this object online.

Control of adverse drug reactions in HIV/AIDS antiretroviral treatment with interchangeable medicines by M. V. Zhuravleva, A. B. Prokofiev, A. S. Podymova, N. G. Berdnikova, S. Yu. Serebrova, E. Yu. Demchenkova

Connect to this object online.

Inhibitors in the Management of Patients with Atherosclerotic Cardiovascular Diseases: Guidelines and Reimbursement Issues by M. V. Zhuravleva, A. B. Prokofiev, E. V. Shikh, S. Yu. Serebrova, G. I. Gorodetskaya, E. Yu. Demchenkova

Connect to this object online.

Evaluation of the Effect of Comorbidity on the Efficacy and Safety of β-Lactam Antibiotics in Patients with Community-Acquired Pneumonia by O. V. Muslimova, E. A. Sokova, A. B. Prokofiev, M. V. Zhuravleva, A. V. Shapchenko, T. V. Alexandrova

Connect to this object online.

Clinical Pharmacology of Antimicrobials: Focus on the Safety of Vancomycin and Linezolid by M. V. Zhuravleva, E. V. Kuznetsova, N. G. Berdnikova, A. B. Prokofiev, T. R. Kameneva, E. Yu. Demchenkova

Connect to this object online.

Nephrotoxicity Biomarkers: Role and Significance in the Diagnosis of Drug-Induced Kidney Injury by O. V. Muslimova, V. A. Evteev, I. A. Mazerkina, E. A. Sokova, A. B. Prokofiev, A. V. Shapchenko, T. V. Alexandrova

Connect to this object online.

Pharmacogenetic Approaches to Enhancing Efficacy and Safety of Statins as Illustrated by the Example of Atorvastatin by R. Ye. Kazakov, O. A. Checha, I. A. Mazerkina, E. Yu. Demchenkova, T. A. Aleksandrova, V. A. Evteev, S. A. Belkov, A. B. Prokofiev

Connect to this object online.

Retrospective Analysis of the Safety of Antibacterial Medicinal Products for Elderly Patients with Community-Acquired Lower Respiratory Tract Infections by G. I. Gorodetskaya, A. B. Prokofiev, S. Yu. Serebrova, E. Yu. Demchenkova, M. V. Zhuravleva, O. A. Demidova, T. V. Alexandrova, I. A. Mazerkina, E. A. Sokova, O. V. Muslimova

Connect to this object online.

Experience of Using Therapeutic Drug Monitoring to Control the Safety of Vancomycin in Intensive Care Unit Patients with Sepsis by A. B. Prokofiev, S. A. Belkov, R. E. Kazakov, N. G. Berdnikova, T. A. Rodina, E. S. Melnikov, A. A. Danko, N. E. Voronova, R. Z. Vafina, A. V. Zavtoniev, D. V. Tsyganko, E. Yu. Demchenkova

Connect to this object online.